| ²é¿´: 2643 | »Ø¸´: 18 | |||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||
mouse103ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
|
[½»Á÷]
Å·Ã˶ÔAPIÌá³öÁËÐÂÒªÇó ÒÑÓÐ15È˲ÎÓë
|
||||
|
Å·Ã˹涨£¬ÖÁ2013ÄêÆð³ö¿ÚÖÁÅ·Ã˵ÄAPI£¬±ØÐëÓб¾¹úÕþ¸®³ö¾ßÖ¤Ã÷¸ÃAPIÊÇÓÉ·ûºÏÅ·ÃËGMP¹¤³§Éú²úµÄ¡£ GMP News 03/05/2012 Import of APIs from Third Countries into the European Union: Template for the written Confirmation of GMP Compliance published for Comments From 2013 on, APIs from Third Countries will be allowed for importation into the European Union when - in addition to the GMP certificate - an enclosed document from the regulatory authority in the exporting countries confirms that: The GMP standards in the exporting country are equivalent to those in the EU The manufacturing plant is regularly and rigorously controlled. These controls should be unannounced. Measures should be taken in case of GMP deviations. The EU must be immediately notified about GMP deviations (by the members states' authorities). This will enforce the Anti-Counterfeiting Directive 2011/62/EU (see also our News from 14 December 2011). On 16 April 2012, the EU Commission aligned on the WHO's model GMP certificate and created a template for comment. The deadline for comment is 1 June 2012. Please also see the Commission consultation paper incl. the template. Note: You will get first hand information about the newest developments regarding manufacture, distribution, and safety of APIs at the "15th APIC/CEFIC European Conference on Acitve Pharmaceutical Ingredients" in Budapest, Hungary, from 7-9 November 2012 |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ÁõÊÏÒ©Òµ | ¡®Ò©Îï¡¢ÓлúºÏ³ÉÑо¿Ô±¡¯×ÊÁÏ´óÈ« |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
ҩѧר˶µ÷¼Á
ÒѾÓÐ2È˻ظ´
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ104È˻ظ´
105500ҩѧµ÷¼Á£¬Ò»Ö¾Ô¸¶¥9£¬Ö÷³ÖÊ¡¼¶´ó´´£¬ÊµÑéÐÍSCI¶þ×÷£¬ËÄÁù¼¶Òѹý£¬Ë«¹ú½±
ÒѾÓÐ6È˻ظ´
ҩѧר˶µ÷¼Á
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ0È˻ظ´
publcifµÄʹÓÃ
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ1È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
»á¼Æ×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
ÒѾÓÐ12È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Å·ÃËÏȽø¹è²ÄÁÏÑо¿È¡µÃÖØ´óÍ»ÆÆ
ÒѾÓÐ6È˻ظ´
FDA/Å·ÃË/ÈÕ±¾ 08-12ÄêÈ«ÇòÅú×¼ÐÂÒ©»ã×ܱ¨¸æ
ÒѾÓÐ94È˻ظ´
API¼¼Êõ¼ø¶¨Ï¸¾úµ½ÖÖ
ÒѾÓÐ9È˻ظ´
Å·ÃËʳƷ°²È«¾ÖÓйØ×ª»ùÒòʳƷµÄȨÍþ±¨¸æ[×¢Òâ]
ÒѾÓÐ11È˻ظ´
GMPÌåϵÏÂAPIÉú²úÅúÁ¿µÄÅäÌ×ÐÔÎÊÌâ
ÒѾÓÐ4È˻ظ´
¡¾½»Á÷¡¿×îÑϸñÉúÎïȼÁϱê׼ŷÃ˵®Éú
ÒѾÓÐ3È˻ظ´
zyz666888
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
ÇáÃèµÐ´
- Ó¦Öú: 277 (´óѧÉú)
- ¹ó±ö: 0.588
- ½ð±Ò: 10044.2
- É¢½ð: 1175
- ºì»¨: 29
- ɳ·¢: 19
- Ìû×Ó: 2740
- ÔÚÏß: 547Сʱ
- ³æºÅ: 587295
- ×¢²á: 2008-08-22
- ÐÔ±ð: GG
- רҵ: ºê¹Û¹ÜÀíÓëÕþ²ß
8Â¥2012-05-25 09:57:45
xbqewpq
ÈÙÓþ°æÖ÷ (ÖøÃûдÊÖ)
»êÙâ
- DRDEPI: 1
- Ó¦Öú: 483 (˶ʿ)
- ¹ó±ö: 1.827
- ½ð±Ò: 8677.9
- É¢½ð: 2014
- ºì»¨: 36
- ɳ·¢: 14
- Ìû×Ó: 2144
- ÔÚÏß: 533.9Сʱ
- ³æºÅ: 1820818
- ×¢²á: 2012-05-16
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
- ¹ÜϽ: ·ÖÎö

2Â¥2012-05-24 12:35:35
wangati
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 124 (¸ßÖÐÉú)
- ½ð±Ò: 4742.2
- É¢½ð: 20
- ºì»¨: 2
- Ìû×Ó: 1944
- ÔÚÏß: 458.5Сʱ
- ³æºÅ: 393309
- ×¢²á: 2007-06-05
- רҵ: Âí¿Ë˼Ö÷Òå˼ÏëÊ·
3Â¥2012-05-24 15:32:02
xbqewpq
ÈÙÓþ°æÖ÷ (ÖøÃûдÊÖ)
»êÙâ
- DRDEPI: 1
- Ó¦Öú: 483 (˶ʿ)
- ¹ó±ö: 1.827
- ½ð±Ò: 8677.9
- É¢½ð: 2014
- ºì»¨: 36
- ɳ·¢: 14
- Ìû×Ó: 2144
- ÔÚÏß: 533.9Сʱ
- ³æºÅ: 1820818
- ×¢²á: 2012-05-16
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
- ¹ÜϽ: ·ÖÎö

4Â¥2012-05-24 20:17:13













»Ø¸´´ËÂ¥
xbqewpq